» Articles » PMID: 23257573

Novel Actions of Oxazolidinones: in Vitro Screening of a Triazolyloxazolidinone for Anticonvulsant Activity

Overview
Journal Med Princ Pract
Publisher Karger
Date 2012 Dec 22
PMID 23257573
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To test the hypothesis that a triazolyloxazolidinone (PH084) has anticonvulsant activity by examining its effects on in vitro seizure models in the rat hippocampus.

Materials And Methods: Whole-cell synaptic currents, action potentials and extracellular population spikes (PS) were recorded in the cell body area of rat hippocampal CA1 region in acutely prepared slices. Chemical [picrotoxin (100 µM) and zero magnesium] and electrical seizures were induced and the effect of PH084 (10 µM) was tested on cellular responses, multiple spikes and spontaneous bursting frequencies.

Results: PH084 depressed evoked excitatory postsynaptic currents, action potential firing frequency and PS amplitude. All of these responses did not recover to baseline after 15-20 min washout of PH084. Perfusion with zero magnesium ion (Mg(2+))-containing buffer converted a single PS to multiple PS (mPS) accompanied by spontaneous burst. PH084 suppressed the mPS and the spontaneous burst frequency and it also suppressed the picrotoxin-induced mPS number. However, it did not affect the frequency of stimulus train-induced after discharge or bursts. Furthermore, 8-10 min pretreatment with PH084 did not affect the ability of zero Mg(2+) buffer, picrotoxin or stimulus train to induce epileptiform activity.

Conclusions: Thus, while PH084 may have potential for anticonvulsant activity against chemically induced seizures, it has little or no potential against electrically induced seizures or in preventing epileptiform discharge.

Citing Articles

Design, synthesis, and antiproliferative evaluation of novel dehydroabietic acid-1,2,3-triazole-oxazolidinone hybrids.

Wu Y, Huang L, Ma X, Zhou X, Li Q, Li F RSC Med Chem. 2024; 15(2):561-571.

PMID: 38389893 PMC: 10880940. DOI: 10.1039/d3md00550j.


Oxazolidinones as versatile scaffolds in medicinal chemistry.

Fernandes G, Scarim C, Kim S, Wu J, Castagnolo D RSC Med Chem. 2023; 14(5):823-847.

PMID: 37252095 PMC: 10211318. DOI: 10.1039/d2md00415a.


Extract Depresses Excitatory Synaptic Transmission and Chemically-Induced Seizures in the Rat Hippocampus.

Amoateng P, Tagoe T, Karikari T, Kukuia K, Osei-Safo D, Woode E Front Pharmacol. 2021; 12:610025.

PMID: 33762938 PMC: 7982396. DOI: 10.3389/fphar.2021.610025.


5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer.

Armentano B, Curcio R, Brindisi M, Mancuso R, Rago V, Ziccarelli I Biomedicines. 2020; 8(2).

PMID: 32085547 PMC: 7168333. DOI: 10.3390/biomedicines8020035.


Synthesis and Biological Evaluation of Novel Dehydroabietic Acid-Oxazolidinone Hybrids for Antitumor Properties.

Wang X, Pang F, Huang L, Yang X, Ma X, Jiang C Int J Mol Sci. 2018; 19(10).

PMID: 30314336 PMC: 6213879. DOI: 10.3390/ijms19103116.

References
1.
Pollard J, French J . Antiepileptic drugs in development. Lancet Neurol. 2006; 5(12):1064-7. DOI: 10.1016/S1474-4422(06)70627-5. View

2.
Jefferys J, Haas H . Synchronized bursting of CA1 hippocampal pyramidal cells in the absence of synaptic transmission. Nature. 1982; 300(5891):448-50. DOI: 10.1038/300448a0. View

3.
Stafstrom C, Grippon S, Kirkpatrick P . Ezogabine (retigabine). Nat Rev Drug Discov. 2011; 10(10):729-30. DOI: 10.1038/nrd3561. View

4.
Schousboe A, Madsen K, White H . GABA transport inhibitors and seizure protection: the past and future. Future Med Chem. 2011; 3(2):183-7. DOI: 10.4155/fmc.10.288. View

5.
Stephen L, Brodie M . Pharmacotherapy of epilepsy: newly approved and developmental agents. CNS Drugs. 2011; 25(2):89-107. DOI: 10.2165/11584860-000000000-00000. View